Increased expression of NSBP1 has been observed in many human cancers, including clear cell renal carcinoma (ccRC) [25], prostate cancer [26], gliomas [27] and meningiomas [28], suggesting its oncogenic role. Here, HMGN5 is linked to prostate carcinoma.